Cargando…
Identifying risk factors for L’Hermitte’s sign after IMRT for head and neck cancer
BACKGROUND: L’Hermitte’s sign (LS) after chemoradiotherapy for head and neck cancer appears related to higher spinal cord doses. IMRT plans limit spinal cord dose, but the incidence of LS remains high. METHODS: One hundred seventeen patients treated with TomoTherapy™ between 2008 and 2015 prospectiv...
Autores principales: | Laidley, Hannah M., Noble, David J., Barnett, Gill C., Forman, Julia R., Bates, Amy M., Benson, Richard J., Jefferies, Sarah J., Jena, Rajesh, Burnet, Neil G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936022/ https://www.ncbi.nlm.nih.gov/pubmed/29728105 http://dx.doi.org/10.1186/s13014-018-1015-0 |
Ejemplares similares
-
Lhermitte's Sign Developing after IMRT for Head and Neck Cancer
por: Lim, Dong C., et al.
Publicado: (2010) -
L’hermitte–Duclos disease in an elderly patient: A case report and review of the literature
por: Ozeren, Ersin, et al.
Publicado: (2014) -
Lhermitte’s Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism
por: Ko, Huaising C., et al.
Publicado: (2015) -
Lhermitte's Sign: The Current Status
por: Khare, Supreet, et al.
Publicado: (2015) -
Ependymal Cyst Presenting with Lhermitte Sign
por: Franceschini, Paulo Roberto, et al.
Publicado: (2013)